| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2019-04-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18fc37cd9e18049af854ada351f054b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b45bdc8c376a952fb8392876ed772b2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66555a38644875029e1883ddda7ce49e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1331de48d5d73b7d08e681ebd78c9b04 |
| publicationDate |
2021-01-13^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210005119-A |
| titleOfInvention |
Patient selection for therapy with adenosine signaling inhibitors |
| abstract |
Described herein is the determination of the relative expression level of the ACPP transmembrane splice variant relative to the expression level of one or more ACPP non-transmembrane splice variant(s) within a given sample from a subject. Measurements denoted by ρ represent association with clinical outcomes for the subject. In some cases, a value of ρ that exceeds a predetermined cutoff may be associated with poor results. A method of determining ρ and giving a predetermined cutoff value is described. Methods of treating cancer are also described. |
| priorityDate |
2018-04-24^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |